Overview

Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia

Status:
Terminated
Trial end date:
2009-05-18
Target enrollment:
Participant gender:
Summary
To evaluate the lon-term safety and tolerability of [S,S]-reboxetine in patients with fibromyalgia
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Reboxetine